We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Aviva Plc | LSE:AV. | London | Ordinary Share | GB00BPQY8M80 | ORD 32 17/19P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.90 | -0.18% | 495.30 | 495.20 | 495.30 | 496.00 | 491.60 | 492.20 | 1,126,104 | 10:27:02 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Insurance Carriers, Nec | 41.43B | 1.09B | 0.3962 | 12.51 | 13.57B |
Date | Subject | Author | Discuss |
---|---|---|---|
09/2/2017 12:11 | You called? £5 Done. What next? The trend is obvious, higher highs and higher lows. It has been taking out the previous minor swing highs (long magenta lines)which were possible resistance zones. The 500 handle is a significant psychological level. It will be interesting to see if there is sufficient pressure to push it through 500 and consolidate. The next target is 525. | bracke | |
09/2/2017 11:37 | Yep! Until bracke comes along.... | uppompeii | |
09/2/2017 08:08 | £5 today? | spoole5 | |
03/2/2017 14:34 | 03 Feb JP Morgan Cazenove Overweight 492.00 553.00 553.00 Reiterates 02 Feb HSBC Hold 492.00 500.00 500.00 Reiterates | skinny | |
26/1/2017 10:23 | 09-Mar-17 Full year 2016 results 06-Apr-17 Ex-dividend date for 2016 final dividend 17-May-17 2016 final dividend payment date (The ADR payment date will be 23 May 2017) 03-Aug-17 Half year 2017 results | togglebrush | |
07/1/2017 12:41 | 'Nuts' to nonetheless. | bracke | |
07/1/2017 12:37 | Nonetheless... | uppompeii | |
07/1/2017 11:47 | I didn't apologise. No need to. I didn't accuse you. | bracke | |
06/1/2017 17:35 | Apology accepted.... | uppompeii | |
06/1/2017 16:17 | uppompeii Can we agree on partial infallibility? As for obfuscation it's the first subject in the Guru Bible. Dr B Good point. I see that there are two blue recent posters. I shall be watching them!! | bracke | |
05/1/2017 19:26 | Have to be a blue member to downvote....I declare up Not Guilty m'lord | dr biotech | |
05/1/2017 18:31 | EG status confers infallibility. It's too late now to hide behind obfuscation. | uppompeii | |
05/1/2017 17:55 | Yeah, right. Quick to declare innocence......too quick. I have never claimed infallibility, merely superior trading....until you know when. | bracke | |
05/1/2017 17:18 | Haha not guilty....though you have an uphill battle to regain infallibility.... | uppompeii | |
05/1/2017 17:07 | OK who gave me the 'thumb down'...... as if I needed to ask!! | bracke | |
04/1/2017 17:11 | It's got to break and hold above a fiver first. That's the next previous swing high to be overcome. | bracke | |
04/1/2017 16:38 | How soon? Have I got time to put the kettle on.... | dr biotech | |
04/1/2017 14:29 | Excellent, soon be back at £13! | uppompeii | |
04/1/2017 08:53 | Av one of the times tips for the year... | dr biotech | |
30/12/2016 08:17 | 09-Mar-17 Full year 2016 results* 06-Apr-17 Ex-dividend date for 2016 final dividend* 07-Apr-17 Record date for 2016 final dividend* 25-Apr-17 Last date for DRIP election for 2016 final dividend * 17-May-17 2016 final dividend payment date (* 03-Aug-17 Half year 2017 results* 05-Oct-17 Ex-dividend date for 2017 interim dividend* 06-Oct-17 Record date for 2017 interim dividend* 27-Oct-17 Last date for DRIP election for 2017 interim dividend * 17-Nov-17 2017 interim dividend payment date | togglebrush | |
19/12/2016 08:50 | Woodford has started to buy Aviva. He has not been in great form recently imho but his record over the last two decades is outstanding. ’Of Aviva he remarked, ‘These included the commencement of a new position in life insurance business, Aviva. In some respects, the investment case for Aviva is similar to that for Legal & General as both companies have good management teams and very attractive valuations, particularly in terms of yield. Aviva, although broadly similar to Legal & General, has a portfolio of different growth drivers in savings and protection markets and we deemed it attractive enough to start building a modest position.’ | dr biotech | |
15/12/2016 08:26 | Good time to be buying insurers chaps :-) | sawadee3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions